Swedish Orphan Biovitrum AB Share Price
Equities
SOBI
SE0000872095
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 441.00 SEK | +1.05% |
|
+0.55% | +32.51% |
| 09:33pm | Sweden's Sobi says positive topline results from pivotal Phase 3 Reduce 2 study of Pozdeutinurad in gout | RE |
| 05-12 | Deutsche Bank raises Sobi price target to SEK 490 (450), reiterates Buy | FW |
| Capitalization | 153B 16.25B 14.03B 12.83B 12.12B 22.41B 1,567B 22.8B 59.58B 741B 60.99B 59.69B 2,587B | P/E ratio 2026 * |
24x | P/E ratio 2027 * | 19x |
|---|---|---|---|---|---|
| Enterprise value | 164B 17.45B 15.06B 13.77B 13.02B 24.06B 1,682B 24.49B 63.97B 796B 65.49B 64.09B 2,778B | EV / Sales 2026 * |
5.11x | EV / Sales 2027 * | 4.3x |
| Free-Float |
52.09% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Swedish Orphan Biovitrum AB
| 1 day | +1.05% | ||
| 1 week | +0.55% | ||
| Current month | +3.09% | ||
| 1 month | +5.50% | ||
| 3 months | +9.59% | ||
| 6 months | +32.67% | ||
| Current year | +32.51% |
| 1 week | 429.2 |  | 445.2 |
| 1 month | 392.2 | | 450 |
| Current year | 322 | | 450 |
| 1 year | 261.2 | | 450 |
| 3 years | 197.9 | | 450 |
| 5 years | 139.55 | | 450 |
| 10 years | 89.5 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Guido Oelkers
CEO | Chief Executive Officer | 61 | 21/05/2017 |
Henrik Stenqvist
DFI | Director of Finance/CFO | 59 | 19/07/2018 |
| Chief Tech/Sci/R&D Officer | 55 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Staffan Schüberg
BRD | Director/Board Member | 57 | 31/12/2019 |
| Director/Board Member | 70 | 31/12/2020 | |
Filippa Stenberg
BRD | Director/Board Member | - | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.05% | +0.55% | +42.07% | +84.83% | 16.17B | |
| -1.10% | -9.86% | +6.28% | -14.49% | 66.11B | |
| +0.96% | +0.75% | +49.53% | +172.88% | 52.82B | |
| +4.34% | +39.50% | +39.50% | +39.50% | 41.34B | |
| +1.60% | +1.28% | -59.00% | -67.14% | 34.22B | |
| +0.89% | -0.99% | +49.40% | -38.26% | 27.73B | |
| +0.34% | -0.23% | +50.37% | +51.28% | 19.39B | |
| -1.79% | -5.54% | +83.18% | -62.71% | 19.09B | |
| +3.97% | -5.17% | +49.28% | +116.67% | 17.59B | |
| -2.23% | -0.71% | +10.71% | +644.70% | 12.85B | |
| Average | +0.88% | -4.05% | +32.13% | +92.73% | 30.73B | |
| Weighted average by Cap. | +0.92% | -4.25% | +26.89% | +58.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 32.07B 3.42B 2.95B 2.7B 2.55B 4.71B 329B 4.8B 12.53B 156B 12.83B 12.55B 544B | 36.38B 3.88B 3.35B 3.06B 2.89B 5.34B 374B 5.44B 14.21B 177B 14.55B 14.24B 617B |
| Net income | 6.25B 666M 575M 526M 497M 919M 64.23B 935M 2.44B 30.39B 2.5B 2.45B 106B | 7.97B 849M 733M 670M 633M 1.17B 81.85B 1.19B 3.11B 38.72B 3.19B 3.12B 135B |
| Net Debt | 11.25B 1.2B 1.04B 946M 895M 1.65B 116B 1.68B 4.4B 54.7B 4.5B 4.4B 191B | 4.01B 427M 369M 337M 319M 589M 41.19B 600M 1.57B 19.49B 1.6B 1.57B 68.02B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/05/26 | 441.00 kr | +1.05% | 222,397 |
| 20/05/26 | 436.40 kr | +0.46% | 312,217 |
| 19/05/26 | 434.40 kr | +0.05% | 247,152 |
| 18/05/26 | 434.20 kr | -1.54% | 470,963 |
| 15/05/26 | 441.00 kr | +0.55% | 463,926 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SOBI Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition